SCHEMBL7995316

SCHEMBL7995316

Cc1nc(N2CC3CCOC3(CN)C2)c(Cl)c2c1c(=O)c(C(=O)OC(=O)C(F)(F)F)cn2C1CC1

nearest known ligand 0.34

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.33
POLB P06746 2/20 0.31
ALDH1A1 P00352 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM1 P11229 1/20 0.31
OPRM1 P35372 1/20 0.31
OPRD1 P41143 1/20 0.31
CACNA1F O60840 1/20 0.30
MAPK1 P28482 1/20 0.30
CACNA1D Q01668 1/20 0.30
CACNA1S Q13698 1/20 0.30
CACNA1C Q13936 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7847239 0.89 KCNH2 (0.40) KCNH2POLBALDH1A1CHRM2CHRM1
Trifluoroacetic Acid SCHEMBL7496710 0.85 KCNH2 (0.33) KCNH2
SCHEMBL8925207 0.82 ALDH1A1 (0.49) KCNH2POLBALDH1A1CHRM2CHRM1
SCHEMBL7993753 0.79 KCNH2 (0.40) KCNH2POLBALDH1A1OPRM1CACNA1F
SCHEMBL7841882 0.78 KCNH2 (0.52) KCNH2POLBALDH1A1OPRM1MEN1
SCHEMBL7495327 0.77 MEN1 (0.34) KCNH2POLBALDH1A1CHRM2CHRM1
Trifluoroacetic Acid SCHEMBL7846826 0.75 ADRB2 (0.40) KCNH2ALDH1A1CHRM2
SCHEMBL7495331 0.72
Trifluoroacetic Acid SCHEMBL7844915 0.72 KCNH2 (0.49) KCNH2POLBALDH1A1CHRM2CHRM1
Trifluoroacetic Acid SCHEMBL8925203 0.70 ALDH1A1 (0.57) KCNH2POLBALDH1A1CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6288081-B1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the gastroduodenal diseases associated therewith BAYER AKTIENGESELLSCHAFT (DE) 2001-09-11 US disclosed